A Population Health Approach to Lipid Management: Primary Care Guidance – Speakers
Promotional series organised and fully funded by Novartis Pharmaceuticals UK Ltd.

MLR ID: 221550 | September 2022
Adverse Event Reporting:
Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard. Adverse events should also be reported to Novartis via uk.patientsafety@novartis.com or online through the pharmacovigilance intake (PVI) tool at www.report.novartis.com
If you have a question about the product, please contact Medical Information on 01276 698370 or by email at medinfo.uk@novartis.com